Pharmacovigilance

December 1-3, 2020 | USA

Pharmacovigilance will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. The entire program will cover the detection, analysis and prevention of adverse drug reactions. It will be studied with the help of case studies and industry experiences. This conference will help the drug safety representatives from the pharmaceutical industry and academic and quality research organizations who wish to understand how to avoid common deficiencies in inspections by learning from the experiences of others, to gain a greater understanding of new and existing pv requirements, and to improve their organizations' compliance with pv requirements.

Spotlight

In March, The European Medicines Agency (EMA) suspended all drugs which were tested for bioequivalence(BE) at Micro Therapeutics Labs. The data provided between June 2012 until 2016 on BE were not acceptable for market authorization.


OTHER PAST CONFERENCES

International Conference and Expo on Toxicology and Applied Pharmacology

June 13-14, 2022 | Italy

Magnus Group extends immense pleasure and honour to invite you to its “International Conference and Expo on Toxicology and Applied Pharmacology" scheduled during June 13-14, 2022 in Rome, Italy.

Making Pharmaceuticals Exhibition Conference And Awards

April 26-27, 2022 | UK

Processing, Medical Devices, Regulatory, Clinical Testing, Research & Development, Operational Excellence, Pharmaceutical Quality, Serialisation, Clinical Trial Testing, Ingredients / Excipients, Microbiology And Pharma, Pharmaceutical Engineering, Packaging & Labelling, New Technologies, Data Management

4th Elets Pharma Leadership Summit 2022

May 11, 2022 | USA

The Covid-19 pandemic has brought about an accelerated transformation in the Indian Pharmaceutical sector. With technology engulfing the entire gamut of the pharma universe, the wide-ranging transformations have unlocked new opportunities.

DIGI-TECH PHARMA And AI 2022

May 10-11, 2022 | USA

The Digi-Tech Pharma & AI 2022 conference brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare industry.

Spotlight

In March, The European Medicines Agency (EMA) suspended all drugs which were tested for bioequivalence(BE) at Micro Therapeutics Labs. The data provided between June 2012 until 2016 on BE were not acceptable for market authorization.

resources